Aussie Trials Show Drug Combo Effective Against Breast Cancer
This article was originally published in PharmAsia News
Phase III trials involving Australian participants taking a popular chemotherapy drug along with the cancer-fighting Avastin (bevacizumab) showed the combination effective against advanced breast cancer. The Sanofi-Aventis drug Taxotere (docetaxel) is widely used in Australia for chemotherapy treatment. Researchers reported at an international cancer conference that trials, including those conducted in Australia, showed combining Taxotere with Genentech's Avastin slowed the progression of HER2-negative advanced breast cancer. (Click here for more
You may also be interested in...
New report shows average out-of-pocket cost per prescription of $10.67 in 2019 was unchanged from 2018. But while the number of dispensed drugs barely increased, sales jumped more than 5%.
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.